Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fecal hemoglobin refers to the presence and concentration of hemoglobin found in stool samples, detected primarily through fecal occult blood tests (FOBT) or fecal immunochemical tests (FIT). It is used as a diagnostic biomarker for gastrointestinal bleeding, most notably in population screening for colorectal cancer, but may also indicate other GI conditions such as polyps, hemorrhoids, diverticulosis, and ulcerative colitis[4][5][6][3]. Quantification of fecal hemoglobin is correlated with risk of advanced neoplasia and colorectal cancer and is utilized to stratify patients for further investigation, typically via colonoscopy[2][5][1]. It is *not* a cellular protein target and does not participate directly in biological regulatory pathways.
None (no mechanisms, this is a biomarker detected in stool)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fecal hemoglobin.